Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.
about
Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signalingMolecular biology of lung cancerTyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical ImplicationsDiscoidin Domain Receptors: Potential Actors and Targets in CancerSquamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterizationFrom Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung CancersALK and ROS1 as targeted therapy paradigms and clinical implications to overcome crizotinib resistanceThe distinctive nature of adenocarcinoma of the lungDifferences in driver genes between smoking-related and non-smoking-related lung cancer in the Chinese populationTargeted therapies for patients with advanced NSCLC harboring wild-type EGFR: what's new and what's enoughLigand-triggered resistance to molecular targeted drugs in lung cancer: roles of hepatocyte growth factor and epidermal growth factor receptor ligandsTargeting angiogenesis in squamous non-small cell lung cancerSystemic and targeted therapies for early-stage lung cancerGenetic characteristics and research progress of targeted therapy in squamous cell carcinomaTargeted therapies in development for non-small cell lung cancerCIViC databaseAssessing the range of kinase autoinhibition mechanisms in the insulin receptor familyLY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft modelsStructural Mechanisms Determining Inhibition of the Collagen Receptor DDR1 by Selective and Multi-Targeted Type II Kinase InhibitorsMolecular pathology of lung cancer: key to personalized medicine.Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.Targeted Therapies in Non-Small Cell Lung Cancer-Beyond EGFR and ALKSquamous cell lung cancer: from tumor genomics to cancer therapeuticsComprehensive genomic characterization of squamous cell lung cancers.Phosphoproteomics of collagen receptor networks reveals SHP-2 phosphorylation downstream of wild-type DDR2 and its lung cancer mutantsTranscriptome sequencing of tumor subpopulations reveals a spectrum of therapeutic options for squamous cell lung cancerGene-expression data integration to squamous cell lung cancer subtypes reveals drug sensitivityPolypharmacology in Precision Oncology: Current Applications and Future ProspectsThe Role of FGFR1 Gene Amplification as a Poor Prognostic Factor in Squamous Cell Lung Cancer: A Meta-Analysis of Published DataA phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors.Beyond histology: translating tumor genotypes into clinically effective targeted therapies.Discoidin domain receptor functions in physiological and pathological conditions.Molecular pathways and therapeutic targets in lung cancerIdentification of novel driver mutations of the discoidin domain receptor 2 (DDR2) gene in squamous cell lung cancer of Chinese patients.Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer.Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients.ALK-rearrangements and testing methods in non-small cell lung cancer: a reviewGenomics of squamous cell lung cancerMYCxing it up with FGFR1 in squamous cell lung cancer.Using functional signature ontology (FUSION) to identify mechanisms of action for natural products.
P2860
Q24604831-E8EBB825-5D6B-4820-980F-62A7358B3D1BQ24606677-14FA1A37-110A-40D0-B601-C1185DC9E1D6Q26741318-61EE0DF6-2AD5-4ED2-BEB1-86F1A319C1D0Q26751157-8483896C-46CA-426C-8D5E-1470879B00D5Q26765060-AF622676-FCDB-462F-AE57-CE85A63C1D61Q26771375-B26ECD9C-C58D-44EC-8A75-742A4F931BE5Q26775347-3E498021-0986-4552-A6CE-F5C58B46DA5BQ26781159-D1CB376A-090C-41AD-A74E-D88A03C6BE26Q26786594-53206CA3-970A-49D6-A0B4-8470BFA752ABQ26799467-1F2054C4-50B7-480F-8E14-487D421AA512Q26829104-29EDAB6C-718D-4B4A-A11A-293E12E68609Q26861341-6227AFFB-741E-4215-A0EC-53BC04761727Q26865490-625A725A-7CEA-4AC0-8E54-E43F4559742EQ26865529-C2B48570-299C-4B30-BB54-EBA30D879759Q27022852-5C45DAA0-D5CF-4945-B7CC-53DCED96B65BQ27612411-C941DE48-95DF-4F23-8D40-8EE04C6FA0B6Q27673414-D2E91389-1903-4E0B-9F47-3C310ECB705DQ27675641-4D90093E-DD85-41D2-A8CA-92BCAF52848BQ27683558-AA990789-7811-4131-AA4A-3C327F32DD3DQ27691299-02A92028-5A49-4529-971A-7F44D1E9D685Q27851654-AC3A4C54-3A0E-41E6-AF11-0412CD9282A8Q28083446-B0530220-AE7C-4A6D-8649-A6880F717A52Q28086951-B69D859D-4B9C-4CF3-AEDF-FF7544E93A3FQ28274701-198BDAD6-5271-45C5-9BFF-2408F31E532EQ28293851-032B3CFA-CCF2-4F31-AD31-0F596D6379BDQ28488566-73A89DBD-0FAB-41B6-9234-AB2374FE9FC3Q30664828-E34B4925-72D0-4D5F-83DC-358F329F5F1EQ30846907-3BEBE11C-F6CB-4B0D-9CA1-3DC6C502CB6CQ31038314-FCBF8286-1866-46FE-8025-19C5A7DAD49FQ33404541-A3E502BE-D29F-4205-9433-27C2DBE0FE96Q33560928-101D9711-DB20-4A9B-B3AF-A063DC9ED088Q33611605-8F2397A1-11E8-478F-B59F-3EE93C8DB055Q33688872-273005D6-2F9D-4BBC-BAF5-41286C1E8CF9Q33690276-4A4022E2-4B13-4CFE-B14C-6D8C525B22F4Q33756818-C61CF930-E183-413F-B1D7-E9963CEF8DCCQ33774682-396F2968-7BCE-4E6A-A8EE-225B201A09BBQ33776835-381AA1B8-5913-480E-9573-736443B94FB7Q33777454-0F49BD43-6B00-4E0E-84BD-195F215FACA5Q33820617-744D5B68-5540-4974-9B79-082E16E3451AQ33822717-E8AECC18-3418-4D7F-9500-649CEF036E05
P2860
Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Mutations in the DDR2 kinase g ...... in squamous cell lung cancer.
@ast
Mutations in the DDR2 kinase g ...... in squamous cell lung cancer.
@en
Mutations in the DDR2 kinase g ...... in squamous cell lung cancer.
@nl
type
label
Mutations in the DDR2 kinase g ...... in squamous cell lung cancer.
@ast
Mutations in the DDR2 kinase g ...... in squamous cell lung cancer.
@en
Mutations in the DDR2 kinase g ...... in squamous cell lung cancer.
@nl
altLabel
Mutations in the DDR2 kinase g ...... t in squamous cell lung cancer
@en
prefLabel
Mutations in the DDR2 kinase g ...... in squamous cell lung cancer.
@ast
Mutations in the DDR2 kinase g ...... in squamous cell lung cancer.
@en
Mutations in the DDR2 kinase g ...... in squamous cell lung cancer.
@nl
P2093
P2860
P50
P3181
P1433
P1476
Mutations in the DDR2 kinase g ...... in squamous cell lung cancer.
@en
P2093
Adam J Bass
Alex H Ramos
Alex Soltermann
Brittany A Woods
Bruce E Johnson
Charles Hatton
Christian Brambilla
Chunxiao Xu
Danila Seidel
David G Beer
P2860
P3181
P356
10.1158/2159-8274.CD-11-0005
P407
P50
P577
2011-06-01T00:00:00Z